Portfolio company
VISCIENT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops novel therapies and drug discovery platforms using three-dimensional human tissue models to treat liver diseases for biopharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ochre-Bio
This company develops RNA-based therapies and human liver data sets for pharmaceutical businesses to treat chronic liver diseases.
ClexBio
This company develops bioengineered vascular tissues and microfluidic hydrogel technology for researchers and clinical partners to treat chronic organ diseases and liver failure.
Satellite Bio
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
Organovo
The company develops three-dimensional human tissues for drug discovery applications for pharmaceutical and biotechnology researchers.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
RadaHaim
This company provides scalable organoid mass production platforms and research services to pharmaceutical firms and clinicians for drug discovery and toxicity screening.
